Role of lectin microarrays in cancer diagnosis

The majority of cell differentiation associated tumor markers reported to date are either glycoproteins or glycolipids. Despite there being a large number of glycoproteins reported as candidate markers for various cancers, only a handful are approved by the US Food and Drug Administration. Lectins,...

Full description

Saved in:
Bibliographic Details
Published inProteomics (Weinheim) Vol. 16; no. 8; pp. 1257 - 1265
Main Authors Syed, Parvez, Gidwani, Kamlesh, Kekki, Henna, Leivo, Janne, Pettersson, Kim, Lamminmäki, Urpo
Format Journal Article
LanguageEnglish
Published Germany Blackwell Publishing Ltd 01.04.2016
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The majority of cell differentiation associated tumor markers reported to date are either glycoproteins or glycolipids. Despite there being a large number of glycoproteins reported as candidate markers for various cancers, only a handful are approved by the US Food and Drug Administration. Lectins, which bind to the glycan part of the glycoproteins, can be exploited to identify aberrant glycosylation patterns, which in turn would help in enhancing the specificity of cancer diagnosis. Although conventional techniques such as HPLC and MS have been instrumental in performing the glycomic analyses, these techniques lack multiplexity. Lectin microarrays have proved to be useful in studying multiple lectin–glycan interactions in a single experiment and, with the advances made in the field, hold a promise of enabling glycomic profiling of cancers in a fast and efficient manner.
Bibliography:ArticleID:PMIC12256
istex:AE5C3A059CDB7B2A9FFCE3BA10473B1E9316BF3E
TEKES-DBT PROVATECT - No. 40089/14
ark:/67375/WNG-L6R2J5KL-J
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
ISSN:1615-9853
1615-9861
DOI:10.1002/pmic.201500404